(PharmaNewsWire.Com, October 12, 2018 ) Congestive heart failure (CHF) treatment devices market is mainly driven by rising prevalence of cardiovascular diseases, technological advancements, and increasing number of cardiovascular surgeries. Additionally, positive reimbursement policies for cardiovascular related surgeries and operations are likely to add new opportunities for this market in the coming years.
Congestive heart failure (CHF) is a condition that affects the ability of the heart muscles to pump sufficient amount of blood. This condition results in shortness of breath, excessive tiredness, and leg swelling. Therefore, it is important to manage heart failure with the help of various devices such as defibrillators, pacemakers available in the market.
The “Global Congestive Heart Failure (CHF) Treatment Devices Market Analysis to 2025” is a specialized and in-depth study of the congestive heart failure (CHF) treatment devices industry with a focus on the global market trend. The report aims to provide an overview of global congestive heart failure (CHF) treatment devices market with detailed market segmentation by product, end user and geography. The global congestive heart failure (CHF) treatment devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
List of Companies mentioned in this study - 1. Medtronic 2. Boston Scientific Corporation 3. Biotronik 4. St. Jude Medical 5. Micromed AS 6. LivaNova 7. ABIOMED 8. HeartWare International, Inc. 9. Jarvik Heart, Inc. 10. Berlin Heart
On the basis of product, the market is segmented into ventricular assist devices (VADs), pacemakers, counter pulsation devices and cardiac resynchronization therapy. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers and others.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global congestive heart failure (CHF) treatment devices market based on product and end user. It also provides market size and forecast till 2025 for overall congestive heart failure (CHF) treatment devices market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
North America holds the largest market share in the market owing to extensive use of medical devices for the management of various cardiovascular diseases and rising emphasis on early diagnosis and treatment of cardiovascular disease. However, Asia Pacific is expected to exhibit tremendous growth opportunities due to the presence of huge patient population and rising awareness about the treatments available for cardiovascular diseases.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key congestive heart failure (CHF) treatment device manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last three years, key development in past five years. Some of the key players influencing the market are Medtronic, Boston Scientific Corporation, Biotronik, St. Jude Medical, Micromed AS, LivaNova, ABIOMED, HeartWare International, Inc., Jarvik Heart, Inc., Berlin Heart and others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
